CCG to fund genetic testing for high cholesterol condition


PERFORMANCE: Dudley Clinical Commissioning Group has become one of only a small number of CCGs to agree funding for DNA testing of familial hyperlipidaemia, a condition which causes cholesterol levels to be much higher than normal from birth.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here